← OPKO HEALTH, INC. OPK
Market Price
$1.39
Market Cap
$1.06B
P/E Ratio
N/A
Revenue (FY 2025)
↓-14.9% YoY
$606.88M
3-Yr CAGR: -15.5%
Net Income
↓-324.0% YoY
-$225.68M
Net Margin: -37.2%
Free Cash Flow
↑8.5% YoY
-$190.82M
FCF Yield: -18.05%
EPS (Diluted)
↓-275.0% YoY
$-0.30
Basic: $-0.30
Return on Equity
Efficiency
-17.8%
ROA: -397.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (OPK)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,221.7M | — | $657.6M | $-25.1M | — | $-0.10 | — | $32.0M | $13.5M | — |
| FY 2017 | $1,067.5M | -12.6% | $1,006.3M | $-308.9M | -1,131.4% | $-0.55 | -450.0% | $-92.1M | $-138.6M | -1,126.8% |
| FY 2018 | $990.3M | -7.2% | $187.1M | $-153.0M | +50.5% | $-0.27 | +50.9% | $-109.1M | $-137.0M | +1.2% |
| FY 2019 | $901.9M | -8.9% | $69.3M | $-314.9M | -105.8% | $-0.53 | -96.3% | $-172.5M | $-185.3M | -35.2% |
| FY 2020 | $1,435.4M | +59.1% | $413.3M | $30.6M | +109.7% | $0.05 | +109.4% | $39.5M | $5.8M | +103.1% |
| FY 2021 | $1,774.7M | +23.6% | $487.6M | $-30.1M | -198.6% | $-0.05 | -200.0% | $38.3M | $6.2M | +6.7% |
| FY 2022 | $1,004.2M | -43.4% | $146.4M | $-328.4M | -989.5% | $-0.46 | -820.0% | $-95.2M | $-119.8M | -2,037.7% |
| FY 2023 | $863.5M | -14.0% | $143.5M | $-188.9M | +42.5% | $-0.25 | +45.7% | $-28.2M | $-44.5M | +62.9% |
| FY 2024 | $713.1M | -17.4% | $218.5M | $-53.2M | +71.8% | $-0.08 | +68.0% | $-183.5M | $-208.5M | -368.8% |
| FY 2025 | $606.9M | -14.9% | $205.9M | $-225.7M | -324.0% | $-0.30 | -275.0% | $-178.5M | $-190.8M | +8.5% |
Valuation
Market Price
$1.39
Market Cap
$1.06B
Enterprise Value
$1.04B
P/E Ratio
N/A
P/B Ratio
0.82
FCF Yield
-18.05%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
33.93%
Operating Margin
-19.35%
Net Margin
-37.19%
Return on Equity (ROE)
-17.80%
Return on Assets (ROA)
-397.82%
Asset Turnover
10.70x
Revenue 3-Yr CAGR
-15.45%
Financial Health & Liquidity
Current Ratio
0.67
Cash Ratio
4.32
Debt / Equity
0.273
Debt / Assets
6.103
Cash & Equivalents
$364.41M
Total Debt
$346.23M
Book Value / Share
$1.68
Cash Flow Efficiency
Operating Cash Flow
-$178.54M
Capital Expenditures (CapEx)
$12.28M
Free Cash Flow
-$190.82M
OCF / Revenue
-29.42%
FCF / Revenue
-31.44%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.30
EPS (Basic)
$-0.30
Dividends / Share
N/A
Book Value / Share
$1.68
EPS YoY Growth
-275.00%
Balance Sheet (FY 2025)
Total Assets
$56.73M
Total Liabilities
$84.41M
Stockholders' Equity
$1.27B
Current Assets
$56.73M
Current Liabilities
$84.41M